The Phage Therapy market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Phage Therapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Phage Therapy market.

Major Players in the Phage Therapy market are:
ATCC
Pherecydes Pharma
Vésale Bioscience
MICREOS
BiomX
Intralytix
Fixed-Phage Limited
Microgen

On the basis of types, the Phage Therapy market is primarily split into:
Escherichia Coli
Staphylococcus
Streptococcus
Pseudomonas
Salmonella
Others

On the basis of applications, the market covers:
Bacterial Dysentery
Infections of the Skin and Nasal Mucosa
Suppurative Skin Infection
Lung and Pleural Infections
Post-operative Wound Infections
Others

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029